Global Biopsy Devices Market – North America is expected to account for higher market share of more than 75% driven by rising number of biopsies in U.S. – Market Analysis and Forecast 2019 – 2026

Global Biopsy Devices Market is expected to reach US$ 4.81 Bn. at a CAGR of 8.5 during the forecast period 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region To know about the Research Methodology :- Request Free Sample Report The growth is coupled with increasing incidences of cancer such as breast, prostate, & lung, and rapid advancement in the technologies. Further, increasing awareness for the diagnosis of chronic diseases is also expected to increase the demand for biopsy devices through the forecast period. Other factors including rising incidences of cancer in the developing regions such as Asia-Pacific, development in the healthcare infrastructure, increasing demand for effective diagnostic procedures are also expected to drive the biopsy market through the forecast period. Moreover, increasing demand for less invasive surgeries and disposable biopsy devices is expected to boost the Global Biopsy Devices Market. Technologically advanced biopsy guidance systems, such as vacuum-assisted guns, are gaining popularity among patients and healthcare providers. Widening base of geriatric population and the introduction of cost-effective and advanced devices are anticipated to further boost the growth of the Global Biopsy Devices Market. Growing cancer-related spending is prompting the need for effective diagnostic procedures. Government and healthcare regulatory bodies across the world are constantly engaged in reducing the excessive costs associated with the treatment of cancer. Primary and secondary healthcare centers in emerging nations are encouraging patients to undergo regular diagnostic examinations. Use of biopsy devices involves a relatively lesser number of hospital stays and therefore, are economically viable. North America had the highest market share in 2017. The market is driven by the factors including the presence of established market players, increasing demand for the advanced technologies such as vacuum-assisted biopsy systems and rapidly growing demand for disposable devices. The U.S. had the highest market in North America driven by increasing number of biopsies held in the country. The U.S. FDA has a less stringent regulatory approval process for medical devices since they are considered at moderate risk. There are several government health initiatives aimed at encouraging individuals to undertake regular cancer screening in the U.S. and thus, drive the market through the forecast period. The Asia Pacific is expected to have a higher growth rate in the forecast period. The growth rate is primarily driven by rapidly improving healthcare infrastructure in countries such as China, Japan, and India. Other factors including the presence of high unmet patient needs and increased incidence of cancer are expected to drive the Global Biopsy Devices Market through the forecast period. According to the World Health Organization (WHO), the number of cancer deaths annually in Asia may reach 6.4 million by 2030, from 4 million in 2007. Needle-based biopsy guns held the highest market share in 2017. The Global Biopsy Devices Market growth is coupled with the factors including rising demand for from soft tissues of internal organs such as breasts, kidneys, and lungs and increasing need for rapid and gentle procurement of cell samples for biopsy. Moreover, an introduction of technologically advanced products such as Aspiration biopsy syringe gun by INRAD Inc. also expected to drive the Global Biopsy Devices Market through the forecast period. The objective of the report is to present comprehensive Global Biopsy Devices Market     including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Biopsy Devices Market   North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Biopsy Devices Market   North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Biopsy Devices Market   North America for Asia Pacific make the report investor’s guide.

Scope Of the Global Biopsy Devices Market:  Inquire before buying

• Global Biopsy Devices Market, By Product

• Needle-based Biopsy Instruments • Core Biopsy Devices • Core Biopsy Guns • Core Biopsy Needles • Aspiration Biopsy Needles • Vacuum-assisted Biopsy Devices • Vacuum-assisted Biopsy Systems • Vacuum-assisted Biopsy Needles • Localization Wires • Procedure Trays • Others •Global Biopsy Devices Market, By Guidance Technique o Ultrasound-guided Biopsy o Stereotactic-guided Biopsy o MRI-guided Biopsy o Others

• Global Biopsy Devices Market,By Application

o Breast Biopsy o Lung Biopsy o Colorectal Biopsy o Prostate Biopsy o Others

•Global Biopsy Devices Market, By End User

o Hospitals o Academic and Research Institutes o Diagnostic and Imaging Centers

The above data will be provided for following regions/countries from 2018-2026 (USD Million)

• North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia

What information is covered in a report?

• Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017.
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Biopsy Devices Market overview 2.1.1. By Products 2.1.2. By Guidance Technique 2.1.3. By Application 2.1.4. By End User Chapter 3 Global Biopsy Devices Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing incidences of cancer 3.2.1.2. Rapid technological advancements 3.2.2. Market Restrains 3.2.2.1. Unawareness for the diagnosis of chronic diseases 3.2.2.2. Lack of technical expertise 3.3. Market share analysis 3.3.1. By Products 3.2. By Guidance Technique 3.3.3. By Application 3.4. By End User 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Biopsy Devices Market, By Products 4.1. Key segment trends 4.2. Needle-based Biopsy Instruments 4.2.1. Market size, by region, 2013 - 2024 4.3. Core Biopsy Devices 4.3.1. Market size, by region, 2019-2026 4.4. Core Biopsy Guns 4.4.1. Market size, by region, 2019-2026 4.5. Core Biopsy Needles 4.5.1. Market size, by region, 2019-2026 4.6. Aspiration Biopsy Needles 4.6.1. Market size, by region, 2019-2026 4.7. Vacuum-assisted Biopsy Devices 4.7.1. Market size, by region, 2019-2026 4.8. Vacuum-assisted Biopsy Systems 4.8.1. Market size, by region, 2019-2026 4.9. Vacuum-assisted Biopsy Needles 4.9.1. Market size, by region, 2019-2026 4.10. Localization Wires 4.10.1. Market size, by region, 2019-2026 4.11. Procedure Trays 4.11.1. Market size, by region, 2019-2026 4.12. Others 4.12.1. Market size, by region, 2019-2026 4.12.2. Key Trends in Global Biopsy Devices Market Chapter 5 Biopsy Devices Market, By Guidance Technique 5.1. Key segment trends 5.2. Ultrasound-guided Biopsy 5.2.1. Market size, by region, 2013 - 2024 5.3. Stereotactic-guided Biopsy 5.3.1. Market size, by region, 2019-2026 5.4. MRI-guided Biopsy 5.4.1. Market size, by region, 2019-2026 5.5. Others 5.5.1. Market size, by region, 2013 - 2024 Chapter 6 Biopsy Devices Market, By Applications 6.1. Key segment trends 6.2. Breast Biopsy 6.2.1. Market size, by region, 2013 - 2024 6.3. Lung Biopsy 6.3.1. Market size, by region, 2019-2026 6.4. Colorectal Biopsy 6.4.1. Market size, by region, 2019-2026 6.5. Prostate Biopsy 6.5.1. Market size, by region, 2019-2026 6.6. Others 6.6.1. Market size, by region, 2019-2026 Chapter 7 Biopsy Devices Market, By End-User 7.1. Key segment trends 7.2. Hospitals 7.2.1. Market size, by region, 2013 - 2024 7.3. Academic and Research Institutes 7.3.1. Market size, by region, 2019-2026 7.4. Diagnostic and Imaging Centers 7.4.1. Market size, by region, 2019-2026 Chapter 8 Biopsy Devices Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2019-2026 8.2.2. Market size, by products, 2019-2026 8.2.3. Market size, by guidance technique, 2019-2026 8.2.4. Market size, by applications, 2019-2026 8.2.5. Market size, by end-user, 2019-2026 8.2.6. U.S. 8.2.6.1. Market size, by products, 2019-2026 8.2.6.2. Market size, by guidance technique, 2019-2026 8.2.6.3. Market size, by applications, 2019-2026 8.2.6.4. Market size, by end-user, 2019-2026 8.2.7. Canada 8.2.7.1. Market size, by products, 2019-2026 8.2.7.2. Market size, by guidance technique, 2019-2026 8.2.7.3. Market size, by applications, 2019-2026 8.2.7.4. Market size, by end-user, 2019-2026 8.3. Europe 8.3.1. Market size, by country, 2019-2026 8.3.2. Market size, by products, 2019-2026 8.3.3. Market size, by guidance technique, 2019-2026 8.3.4. Market size, by applications, 2019-2026 8.3.5. Market size, by end-user, 2019-2026 8.3.6. Germany 8.3.6.1. Market size, by products, 2019-2026 8.3.6.2. Market size, by guidance technique, 2019-2026 8.3.6.3. Market size, by applications, 2019-2026 8.3.6.4. Market size, by end-user, 2019-2026 8.3.7. UK 8.3.7.1. Market size, by products, 2019-2026 8.3.7.2. Market size, by guidance technique, 2019-2026 8.3.7.3. Market size, by applications, 2019-2026 8.3.7.4. Market size, by end-user, 2019-2026 8.3.8. France 8.3.8.1. Market size, by products, 2019-2026 8.3.8.2. Market size, by guidance technique, 2019-2026 8.3.8.3. Market size, by applications, 2019-2026 8.3.8.4. Market size, by end-user, 2019-2026 8.3.9. Spain 8.3.9.1. Market size, by products, 2019-2026 8.3.9.2. Market size, by guidance technique, 2019-2026 8.3.9.3. Market size, by applications, 2019-2026 8.3.9.4. Market size, by end-user, 2019-2026 8.3.10. Italy 8.3.10.1. Market size, by products, 2019-2026 8.3.10.2. Market size, by guidance technique, 2019-2026 8.3.10.3. Market size, by applications, 2019-2026 8.3.10.4. Market size, by end-user, 2019-2026 8.4. Asia Pacific 8.4.1. Market size, by country, 2019-2026 8.4.2. Market size, by products, 2019-2026 8.4.3. Market size, by guidance technique, 2019-2026 8.4.4. Market size, by applications, 2019-2026 8.4.5. Market size, by end-user, 2019-2026 8.4.6. India 8.4.6.1. Market size, by products, 2019-2026 8.4.6.2. Market size, by guidance technique, 2019-2026 8.4.6.3. Market size, by applications, 2019-2026 8.4.6.4. Market size, by end-user, 2019-2026 8.4.7. China 8.4.7.1. Market size, by products, 2019-2026 8.4.7.2. Market size, by guidance technique, 2019-2026 8.4.7.3. Market size, by applications, 2019-2026 8.4.7.4. Market size, by end-user, 2019-2026 8.4.8. Japan 8.4.8.1. Market size, by products, 2019-2026 8.4.8.2. Market size, by guidance technique, 2019-2026 8.4.8.3. Market size, by applications, 2019-2026 8.4.8.4. Market size, by end-user, 2019-2026 8.4.9. Australia 8.4.9.1. Market size, by products, 2019-2026 8.4.9.2. Market size, by guidance technique, 2019-2026 8.4.9.3. Market size, by applications, 2019-2026 8.4.9.4. Market size, by end-user, 2019-2026 8.5. Latin America 8.5.1. Market size, by country, 2019-2026 8.5.2. Market size, by products, 2019-2026 8.5.3. Market size, by guidance technique, 2019-2026 8.5.4. Market size, by applications, 2019-2026 8.5.5. Market size, by end-user, 2019-2026 8.5.6. Argentina 8.5.6.1. Market size, by products, 2019-2026 8.5.6.2. Market size, by guidance technique, 2019-2026 8.5.6.3. Market size, by applications, 2019-2026 8.5.6.4. Market size, by end-user, 2019-2026 8.5.7. Brazil 8.5.7.1. Market size, by products, 2019-2026 8.5.7.2. Market size, by guidance technique, 2019-2026 8.5.7.3. Market size, by applications, 2019-2026 8.5.7.4. Market size, by end-user, 2019-2026 8.5.8. Mexico 8.5.8.1. Market size, by products, 2019-2026 8.5.8.2. Market size, by guidance technique, 2019-2026 8.5.8.3. Market size, by applications, 2019-2026 8.5.8.4. Market size, by end-user, 2019-2026 8.6. Middle East and Africa 8.6.1. Market size, by country, 2019-2026 8.6.2. Market size, by products, 2019-2026 8.6.3. Market size, by guidance technique, 2019-2026 8.6.4. Market size, by applications, 2019-2026 8.6.5. Market size, by end-user, 2019-2026 8.6.6. South Africa 8.6.6.1. Market size, by products, 2019-2026 8.6.6.2. Market size, by guidance technique, 2019-2026 8.6.6.3. Market size, by applications, 2019-2026 8.6.6.4. Market size, by end-user, 2019-2026 8.6.7. Saudi Arabia 8.6.7.1. Market size, by products, 2019-2026 8.6.7.2. Market size, by guidance technique, 2019-2026 8.6.7.3. Market size, by applications, 2019-2026 8.6.7.4. Market size, by end-user, 2019-2026 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. C. R. Bard, Inc. 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. Becton, Dickinson and Company 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. Cook Group Incorporated 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. Devicor Medical Products, Inc. 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Argon Medical Devices 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. B. Braun Melsungen AG 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Cardinal Health, Inc. 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.4.8. Olympus Corporation 9.4.8.1. Company overview 9.4.8.2. Key financials 9.4.8.3. Product landscape 9.4.8.4. Strategic initiatives 9.4.8.5. SWOT analysis 9.4.9. Boston Scientific Corporation 9.4.9.1. Company overview 9.4.9.2. Key financials 9.4.9.3. Product landscape 9.4.9.4. Strategic initiatives 9.4.9.5. SWOT analysis 9.4.10. FUJIFILM Holdings Corporation 9.4.10.1. Company overview 9.4.10.2. Key financials 9.4.10.3. Product landscape 9.4.10.4. Strategic initiatives 9.4.10.5. SWOT analysis 9.4.11. INRAD, Inc. 9.4.11.1. Company overview 9.4.11.2. Key financials 9.4.11.3. Product landscape 9.4.11.4. Strategic initiatives 9.4.11.5. SWOT analysis 9.4.12. Medtronic plc 9.4.12.1. Company overview 9.4.12.2. Key financials 9.4.12.3. Product landscape 9.4.12.4. Strategic initiatives 9.4.12.5. SWOT analysis 9.4.13. Leica Biosystems 9.4.13.1. Company overview 9.4.13.2. Key financials 9.4.13.3. Product landscape 9.4.13.4. Strategic initiatives 9.4.13.5. SWOT analysis 9.4.14. Hologic, Inc. 9.4.14.1. Company overview 9.4.14.2. Key financials 9.4.14.3. Product landscape 9.4.14.4. Strategic initiatives 9.4.14.5. SWOT analysis 9.4.15. Ethicon EndoSurgery Inc. 9.4.15.1. Company overview 9.4.15.2. Key financials 9.4.15.3. Product landscape 9.4.15.4. Strategic initiatives 9.4.15.5. SWOT analysis 9.4.16. Veran Medical Technologies 9.4.16.1. Company overview 9.4.16.2. Key financials 9.4.16.3. Product landscape 9.4.16.4. Strategic initiatives 9.4.16.5. SWOT analysis 9.4.17. Boston Scientific Corporation 9.4.17.1. Company overview 9.4.17.2. Key financials 9.4.17.3. Product landscape 9.4.17.4. Strategic initiatives 9.4.17.5. SWOT analysis 9.4.18. MDxHealth 9.4.18.1. Company overview 9.4.18.2. Key financials 9.4.18.3. Product landscape 9.4.18.4. Strategic initiatives 9.4.18.5. SWOT analysis 9.4.19. Mauna Kea Technologies 9.4.19.1. Company overview 9.4.19.2. Key financials 9.4.19.3. Product landscape 9.4.19.4. Strategic initiatives 9.4.19.5. SWOT analysis 9.4.20. Argon Medical Devices, Inc 9.4.20.1. Company overview 9.4.20.2. Key financials 9.4.20.3. Product landscape 9.4.20.4. Strategic initiatives 9.4.20.5. SWOT analysis 9.4.21. Intact Medical Corp. 9.4.21.1. Company overview 9.4.21.2. Key financials 9.4.21.3. Product landscape 9.4.21.4. Strategic initiatives 9.4.21.5. SWOT analysis 9.4.22. Carefusion Corporation 9.4.22.1. Company overview 9.4.22.2. Key financials 9.4.22.3. Product landscape 9.4.22.4. Strategic initiatives 9.4.22.5. SWOT analysis 9.4.23. Devicor Medical Products, Inc. 9.4.23.1. Company overview 9.4.23.2. Key financials 9.4.23.3. Product landscape 9.4.23.4. Strategic initiatives 9.4.23.5. SWOT analysis 9.4.24. DTR Medical 9.4.24.1. Company overview 9.4.24.2. Key financials 9.4.24.3. Product landscape 9.4.24.4. Strategic initiatives 9.4.24.5. SWOT analysis 9.4.25. Cardinal Health Inc. 9.4.25.1. Company overview 9.4.25.2. Key financials 9.4.25.3. Product landscape 9.4.25.4. Strategic initiatives 9.4.25.5. SWOT analysis

About This Report

Report ID 10810
Category Healthcare
Published Date oct 2019
Updated Date Dec 2020
Contact Us